Emboline, Inc. is a biotechnology company based in Santa Cruz, California, specializing in the development of innovative medical devices aimed at treating vascular conditions. The organization focuses on advanced technologies for embolization, which involves blocking blood vessels to prevent blood flow to tumors or other abnormal tissues. With a commitment to improving patient outcomes, Emboline leverages cutting-edge research in the fields of interventional radiology and minimally invasive procedures.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

31 Patents

#5 in Santa Cruz, CA

#2,611 in California

#10,921 in US

#21,238 in the World

Santa Cruz, CA, United States of America

Emboline, Inc.

Forward Citations = 487

9 inventors:

Amir Belson (23 out of 157 patents)

Scott M Russell (14 out of 47 patents)

Stephen J Kleshinski (7 out of 46 patents)

4. Erik Krahbichler (4 out of 13 patents)

5. Amir Belson (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emboline, Inc.. Retrieved from https://idiyas.com/company/emboline

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]